RAPT Therapeutics Inc (RAPT)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -115.556 | -60.244 | -55.763 | -51.964 | -43.579 | -36.071 | -53.146 |
Return on Equity (%) | 93.31 | 45.32 | 358.428 | -59.664 | -47.635 | -38.855 | -59.56 |
Return on Invested Capital (%) | -127.521 | -67.415 | -64.968 | -61.413 | -48.188 | -40.413 | -66.127 |
Operating Margin (%) | N/A | N/A | N/A | -1029.393 | -1814.949 | -5490.373 | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | -1049.028 | -1814.949 | -5490.373 | N/A |
Book Value Per Share | 8.756 | 12.142 | 3.349 | 4.205 | 6.306 | 7.157 | 4.275 |
Earnings Per Share | -5.513 | -6.858 | -1.969 | -2.135 | -2.342 | -2.448 | -3.396 |
Cash Per Share | 8.998 | 12.104 | 3.544 | 1.006 | 0.813 | 1.137 | 1.38 |
Working Capital Per Share | 8.52 | 11.463 | 3.263 | 4.192 | 6.205 | 6.962 | 4.069 |
Operating Profit Per Share | N/A | N/A | N/A | 0.204 | 0.129 | 0.045 | N/A |
EBIT Per Share | -5.513 | -6.858 | -1.939 | -2.095 | -2.342 | -2.448 | -3.396 |
EBITDA Per Share | -5.513 | -6.858 | -1.939 | -2.095 | -2.342 | -2.448 | -3.396 |
Free Cash Flow Per Share | -5.562 | -6.428 | -1.99 | -2.164 | -2.35 | -2.453 | -3.398 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 5,28M | 5,27M | 21,83M | 24,77M | 29,56M | 34,25M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 34,25M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 63,27M |
Ratio cours/bénéfice | -0,51 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 1,24 |
Ratio prix/valeur comptable | 0,4 |
Rendement de dividende | - |
Actions en circulation | 34,96M |
Volume moyen (1 semaine) | 38,94M |
Volume moyen (1 mois) | 8,47M |
Variation sur 52 semaines | -93,21% |
Plus haut sur 52 semaines | 27,35 |
Plus bas sur 52 semaines | 0,78925 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales